# CANAGLIFLOZIN
> **ANDA210297** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2020-11-20
## Drug
- **FDA Application Number:** ANDA210297
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CANAGLIFLOZIN
- **Generic name:** Canagliflozin
- **Active ingredients:** CANAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SANDOZ INC
- **First approval:** 2020-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210297)
---
*AI Analytics · CC0 1.0*